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Patients managed in European or North American cancer centres have a variety of ethnic backgrounds and primary languages. To
gain insight into the impact of ethnic origin, we have investigated understanding of disease status and quality of life (QoL) for 202
patients. Patients completed questionnaires in their first language (52 English, 50 Chinese, 50 Italian, 50 Spanish or Portuguese),
including the Functional Assessment of Cancer Therapy – General (FACT-G) QoL instrument, questions about disease status,
expectations of cure and the language and/or type of interpretation used at initial consultation. Physicians also evaluated their status
of disease and expectation of cure, and performance status was estimated by a trained health professional. The initial consultation
was usually provided in English (except for 32% of Chinese-speaking patients); interpretation was provided by a family member for
34% of patients with limited English proficiency (LEP) and by a bilingual member of staff for 21%. Patients underestimated their extent
of disease and overestimated their probability of cure (P¼0.001 and o0.0001, respectively). Estimates of probability of cure by the
English speakers were closer to those of their physicians than the other groups (P¼0.02). English-speaking patients reported better
and Italian-speaking patients poorer overall QoL (Po0.001 for Italian vs other groups). Performance status was correlated with QoL
and most closely related with the extent of disease. Understanding of cultural differences is important for optimal management of
patients with cancer.
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In many countries and for many ethnic groups, disclosure of the
diagnosis of cancer to patients, as well as information regarding
their stage of disease and prognosis, remain controversial issues in
the doctor–patient relationship. A barrier to doctor–patient
communication is also introduced when patients do not speak
the same first language as their physicians, as is common for
patients from some immigrant populations in North America and
Europe. Often, there are substantial differences between the
information that the physician has tried to convey, and that
understood by cancer patients (Olweny, 1997). The quality of
information understood by patients may be important for their
understanding of the evolution of their disease and their
compliance with treatment regimens. Poor understanding because
of difficulties of language and interpretation might lead to
suboptimal management of cancer patients.
Disclosure of information about serious illness varies markedly
among different countries and ethnic groups due to differing
cultural, ethical and legal concerns. In general, North American
and Northern European populations expect more complete
disclosure of information than Southern European populations
(Perez-Stable et al, 1992; Mitchell, 1998; Galanti, 2000), although a
survey of Portuguese-speaking cancer patients found that most of
them desired full information (Pimentel et al, 1999). A survey
comparing perceptions of cancer by people of Southern European
origin (Latinos) and English speakers (Anglos) found that Latinos
were more likely than Anglos to believe that having cancer is like
getting a death sentence, and that they would prefer not to know if
they had incurable cancer (Perez-Stable et al, 1992). Beliefs about
cancer also differ among ethnic groups: for example, some
Hispanic patients believe that ‘its a punishment of God’ and/or
that ‘destiny cannot be changed’ (Shankar and Figueroa-Valles,
1999). In some Asian countries, many patients do not know what
cancer is (Phipps et al, 1999), or have major misconceptions about
the disease (Bottorff et al, 1998).
The above studies suggest that the quality of life (QoL) of
patients with cancer may depend not only on physical symptoms
due to the disease and its treatment, but also on knowledge, or lack
thereof, about the status of their disease. Several studies have
analysed the relationship between characteristics of patients from
different backgrounds and their disease and health-related QoL.
Factors that contribute substantially to variations in QoL include
ethnic/cultural origin (Kim and Rew, 1994; de Haes and
Olschewski, 1998), as well as performance status, overall expecta-
tions of treatment, age, living conditions and the type of care that
patients receive (Ganz et al, 1993; Wan et al, 1997). If different
components of QoL have a variable impact on overall QoL among
people speaking different languages and of different ethnic origin,
it is important to develop questionnaires that are valid for different
populations. The translation of questionnaires developed in one
culture into the language of another can be problematic because of
difficulties in achieving equivalent conceptual dimensions (Cella
et al, 1993; Hays et al, 1993; Sartorius and Kuyken, 1994; The
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lWHOQOL Group, 1994; Yabroff et al, 1996; Ware et al, 1998).
Despite these problems, several QoL questionnaires, including the
Functional Assessment of Cancer Therapy – General (FACT-G)
instrument used in the present study, have been translated into
many languages and validated for different ethnic groups
(Aaronson et al, 1992; Bonomi et al, 1996).
Toronto is a multicultural city, with about 50% of the population
of Caucasian origin who use English as their first language, while
the remaining 50% includes several large (and many smaller)
ethnic minorities with different cultures and languages. The
problem of providing optimal care to patients of diverse ethnic
origin is particularly common in Toronto, but reflects that of many
other large North American and European cities. We therefore
planned the present study to provide preliminary information
about possible inter-relationships between the first language of
patients, their perceptions of their disease and their QoL. We also
sought to determine the possible influence of the language used in
the initial consultation and the type of interpreter, if presented in
English. All questionnaires, including the consent form, were
presented in the first language of the patients. We included
performance status, assessed by a health professional, because this
might reflect aspects of QoL that are less dependent on language,
ethnic origin and cultural beliefs. Our study was exploratory, but
based on clinical observation and on literature cited above we
established the following primary hypotheses.
1. English-speaking patients will have better knowledge and
understanding of their disease than those who speak primarily
Southern European or Chinese languages.
2. Patients with poorer knowledge of their disease status will have
poorer QoL.
PATIENTS AND METHODS
Patients
This was a cross-sectional study in which patients were assessed
once during a visit to a clinic at the Princess Margaret Hospital,
Toronto, Canada’s largest cancer centre. The study was approved
by the Research Ethics Board of the Institution.
Patients were included in the study if they had a malignancy of
any type or stage, and were being treated or assessed as
outpatients. They were eligible if they were older than 18 years
and belonged to one of the following language groups: English,
Italian, Chinese (Mandarin or Cantonese, with a common written
language) or Spanish/Portuguese. Patients with a history of
psychiatric disease, drug or alcohol abuse or major chronic illness
other than cancer were excluded. Eligible patients were provided
with a consent form that had been professionally translated into
their own language. Consenting patients then completed the
questionnaires described in the following section.
Questionnaires
Forms were constructed to assess demographic information, the
patient’s knowledge about the status of their disease and their
expectation of cure and their satisfaction with the information
received. The demographic questionnaire asked about age on
leaving school and about further training or education; whether
the patient was working and if so the type of work and income
bracket; whether they were living with a partner and had children
at home; whether they were born in Canada and if not at which age
they immigrated; their first and second languages at home; and
their religion (if any). The second questionnaire asked patients to
rate their symptoms on a 0–4þ scale with verbal descriptors
similar to those used to generate the ECOG Performance scale. It
asked them to name their type of disease, whether it was a
particular type, and which parts of the body were affected. It
provided a check list of treatments received during the last 3
months and asked if doctors had taken time to explain the nature
of disease and the chance that it might be cured (with yes/no
answers). The form asked if the patients would like to know
anything else (yes/no), with an open format to indicate what, and
asked them to rate satisfaction on a 1þ (not at all satisfied) to 5þ
(very satisfied) scale. It asked about language of initial consulta-
tion, and if English was used, whether there was translation and by
whom. Finally, it asked patients ‘What do you think is the chance
that your disease will be cured?’ and asked them to circle their best
estimate (choices from 0 to 100% in 10% increments). Patients
then completed the FACT-G QoL questionnaire followed by
questions about whether they thought any items were missing or
difficult to understand, and whether it was upsetting, indiscreet or
annoying.
Forms generated for this study, including the consent form,
were translated by professional translators into each of the four
languages. Translations into each language were reviewed by focus
groups of 3–4 bilingual volunteers, and their feedback was used to
improve linguistic and conceptual equivalence. The translated
questionnaires were then pilot-tested on 27 patients and final
adjustments were made before proceeding with the study.
The FACT-G has been translated into 43 different languages
using an established and rigorous translation methodology
(Bonomi et al, 1996). The FACT-G is a 27-item compilation of
general questions divided into four domains or subscales (Physical
Well-being, Social-Family Well-being, Emotional Well-being and
Functional Well-being). The total QoL score can be derived from
the sum of the four subscale scores. In the present study, Version 4
of the FACT-G was used (Cella, 1997). Each patient completed the
FACT-G in his/her first language.
One of the physician investigators reviewed the patient record
and completed the ‘evaluation of disease by physician form’. If
necessary he/she sought the advice of the managing physician to
estimate the probability of cure of the disease. Performance status,
using the Eastern Co-operative Oncology Group scale, was
assessed by a trained research assistant (Oken et al, 1982).
Statistical analysis
This study was exploratory in nature, and there were insufficient
data in the literature to provide expected differences that relate to
our primary hypotheses. The sample size for the present study was
therefore based on feasibility rather than on expected differences
in outcome. However, with the available sample size (52 English
speakers and 150 non-English speakers), there is about 80% power
to detect a 20% difference in the primary end points between
speakers of different languages.
Descriptive statistics were used to analyse the demographic data
for each language group, and the scores on the QoL questionnaire,
its sub-scales and the global QoL score. Descriptive statistics were
also used to describe the patient’s knowledge of disease status,
their estimates of likelihood of cure and their satisfaction with the
information that they had received.
Disease status was classified as local, locoregional or metastatic
(obtained from the hospital record), and agreement between
patients and doctors with respect to this classification was
compared using the McNemar w
2 test. The difference between
expectations of cure by patients and doctors was compared using
the paired t-test. The relationship between the accuracy of the
patient’s assessment of their disease status and probability of cure
(as defined by physicians) and language of first consultation, type
of interpretation, and ethnic origin were further examined using
the w
2 test or ANOVA as appropriate.
To establish whether differences in language groups influence
QoL scores, both univariate and multiple variable models were
used to examine unadjusted and adjusted effects on QoL. In the
multiple variable model, the demographic factors of gender, age,
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were considered as potential confounders. A second multivariate
analysis explored the effects of language group on performance
status, with inclusion of the same potential confounding variables.
The variables in the two models were designated prior to study
analysis and not selected on the basis of a statistical rule; all of the
potential confounding variables were kept in the model regardless
of their significance in univariate analysis.
We used the Spearman correlation coefficient to determine
possible relationships between (i) knowledge of disease stage
(correct or incorrect assessment of local, locoregional or meta-
static) and (ii) difference in expectation of cure between doctor
and patient, with overall QoL, as determined by the score on the
FACT-G. In a hypothesis-generating analysis, we used similar
methodology to explore relationships between accuracy of knowl-
edge of disease and probability of cure with the four domains of
QoL defined by the FACT-G: physical, emotional, social/family and
functional.
All data storage and analysis were performed using the
Statistical Analysis System (SAS) software package (SAS Institute
Inc, 1990). Corrections were not applied for multiple comparisons.
Apart from tests of the a priori hypotheses, only P-values o0.01
should be regarded as suggestive of significance, and results
should be regarded as exploratory.
RESULTS
Patients
A total of 202 patients were recruited: 52 English-speaking, 50
Chinese-speaking, 50 Italian-speaking and 50 Portuguese or
Spanish-speaking patients. Of patients who were invited to
participate in the study, 15% (nine out of 61) of English, 18%
(11 out of 61) of Chinese, 25% (17 out of 67) of Portuguese or
Spanish and 47% (44 out of 94) of Italian-speaking patients refused
to participate (Po0.0001 Italians vs others).
Participants were first asked which language they spoke at home
and whether they were born in Canada. Among the English-
speaking group, 75% were born in Canada, but only 4% of the
Italian-speaking, and none of the Chinese, Portuguese or Spanish-
speaking participants were born in Canada.
The sample demographics of age, educational level, employ-
ment, annual income, living situation, performance status, type of
cancer and disease status are shown in Table 1. The median age
was 56 years for the entire population, with older patients in the
Italian patient group (median 64 years). Consistent with their older
age distribution, fewer Italian-speaking patients were working
(10% compared to 28–38% in the other groups). The English-
speaking group had better Performance Status (P¼0.004; English-
speaking vs others). The overall differences in age distribution,
education, employment and income were statistically significant. A
major difference between the groups is that the Chinese-speaking
population included a high proportion of patients with nasophar-
yngeal cancer, which is common in this ethnic group due to
endemic infection with the Epstein–Barr virus.
The initial consultation
For about one-third of the patients in each ethnic group with
limited English proficiency (LEP), the initial consultation was
received in English without interpretation (35% for Chinese, 32%
for Italian and 40% Spanish or Portuguese-speaking patients)
(Figure 1). Of the Chinese-speaking patients, 32% received an
Table 1 Sociodemographic characteristics of study sample
First language English (n¼52) Chinese (n¼50) Spanish/Port. (n¼50) Italian (n¼50) P-value (overall)
Median age (years) 55 52 55 64 0.0001
Interquartile range 46–64 44–59 47–68 56–72
Education
School only (%) 8 38 51 54 o0.0001
Further education (%) 43 34 34 44
University educated (%) 49 28 15 2
Employment (%) 38 28 32 10 0.01
Annual income
(median, CAD$ 1000) 30–40 20–30 20–30 20–30 0.001
Living with a partner (%) 67 84 75 72 0.27
Performance status
0 (%) 43 31 26 32 0.06
1 (%) 47 38 39 32
2/3 (%) 10 31 35 36
Type of cancer
Breast (%) 32 42 25 13
Gynaecological (%) 12 7 8 9
Head and neck (%) 2 31 2 0
Gastrointestinal (%) 4 4 13 27
Genitourinary (%) 18 0 17 9
Haematologic (%) 18 4 13 20
Lung (%) 2 7 2 7
Other (%) 10 4 21 16
Disease status
Local (%) 23 30 25 27 0.57
Locoregional (%) 21 31 22 15
Metastatic (%) 56 39 53 58
Cancer and ethnic origin
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physicians. Interpretation was provided by a family member for
18% of the Chinese, 49% of the Italian and 43% of the Spanish or
Portuguese-speaking patients. A total of 15 patients (10 Chinese,
three Italian and two Spanish or Portuguese-speaking) indicated
more than one option for the language of consultation and its
interpretation, indicating the use of different strategies in different
parts of the consultation.
Most of the patients were either ‘quite’ or ‘very’ well satisfied
with the information received (Figure 2A). However, many
patients would like to have received more information about their
disease: 38% of English, 63% of Chinese, 26% of Italian and 44% of
Spanish or Portuguese-speaking patients (Figure 2B).
Understanding of disease status and probability of cure
Some patients found these questions difficult and 56 (28%) of them
did not provide information about the extent of their disease and
40 (20%) did not estimate their chance of cure. Differences
between the responding patients in the four language groups
regarding their understanding of the stage of their disease and that
indicated by their hospital record are shown in Table 2; these
differences are highly significant (P¼0.001). More than half of the
patients with metastatic cancer believed that their disease had not
spread, although 27% of the patients with locoregional disease
believed that they had distant metastases. Essentially, all patients
estimated their probability of cure to be higher than that estimated
by physicians (Po0.0001), and median values of these estimates
are shown in Figure 3. The difference between patient and
physician estimates of probability of cure was greater for the LEP
patients (means: 73 vs 33%) than for English-speaking patients
(means: 56% vs 35%) (P¼0.02 for difference of English vs LEP
groups).
For the LEP groups, we analysed the influence of language of
consultation and the type of interpretation used (if any) on (i)
accuracy of the patient’s understanding of disease status and (ii)
expectation of cure. These data are presented in Table 3. There are
nonsignificant trends for patients who received their initial
consultation in English (without interpretation) to have less
accurate knowledge of disease status than those who had a
consultation in their own language or for whom interpretation was
provided. There were also trends for those with an initial
consultation in English or with a family member interpreting to
have the most unrealistic expectations of cure.
Quality of life
Very few patients found the QoL questionnaire to be upsetting
(0–3%) or indiscreet (0–5%), although some of the English-
speaking patients found some questions to be annoying (15%
compared to p1% for the LEP patients).
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Figure 1 Language and type of interpretation at first consultation. (15
patients – 10 Chinese, three Italian and two Spanish/Portuguese-speaking –
indicated a mixed consultation using their own language and English with
interpretation and are represented in both categories in the figure.)
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Figure 2 Satisfaction with the information received. (A) A Percentage of
patients who are quite well or very well satisfied. (B) Percentage of patients
who would like to have received more information.
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lThe comparison of QoL among the ethnic groups is shown in
Figure 4, where higher scores indicate better QoL. The Italian-
speaking patients had the poorest QoL, both in their global
evaluation, and in the domains of Social-Family Well-being,
Emotional Well-being and Functional Well-being. Differences
between Italian-speaking patients and other groups were statisti-
cally significant (P¼0.001) for global QoL and for Physical and
Functional Well-being (P¼0.03 and P¼0.0001, respectively) in
the crosscultural comparisons. Although more Italian-speaking
patients were retired, removing the items in the FACT-G related to
work had no effect on these differences in evaluation of QoL. The
inclusion of other possible confounding variables in a multivariate
analysis (see below) also did not change the conclusion that the
Italian group had the poorest QoL. Each domain was rated on the
questionnaire to be about equally important by each group,
although absolute levels of the rating scales used were lower among
Chinese-speaking patients (data not shown).
We have evaluated the interaction between QoL and language
group with the inclusion of the possible confounding factors of
status of disease (local, locoregional or metastatic), gender, age,
marital status and level of education (Table 4). By univariate
analysis, we found ethnic origin, status of disease and education to
have a significant influence on QoL. In the multivariate analysis,
status of disease predicted QoL (P¼0.002), and being Italian-
speaking predicted poorer QoL compared with English-speaking
patients (P¼0.006), with only nonsignificant trends when the
other groups were compared to English-speakers. We undertook a
similar analysis of the effects of the same factors on Performance
status (assessed by the research assistant) which, as expected, was
highly correlated (Po0.0001) with QoL. Not surprisingly, the
major factor influencing Performance status was the status of
disease (P¼0.002), and there were only nonsignificant trends for
those of non-English language groups to have poorer Performance
status than English-speaking patients.
We also undertook supplementary analyses with (a) only
socioeconomic and demographic variables in the model and (b)
with language also included. The model without language can
interpret about 9% of the variation in QoL, and language can
account for about 3% more variation. After controlling for the
sociodemographic factors, language was still a significant predictor
of QoL.
There was no correlation between accuracy of knowledge of
stage of disease (local, locoregional or metastatic) and QoL. There
was, however, a correlation between the difference in estimates of
cure by physician and patient, and overall QoL (P¼0.005), with
patients having more realistic estimates of probability of cure
having better QoL. In the exploratory analysis with each domain of
Table 2 Estimates of extent of disease by physicians and patients
Physician
Locoregional Metastatic Total
Patients Locoregional 45 43 88 (63%)
Metastatic 17 35 52 (37%)
Total 62 (44%) 78 (56%) 140 (100%)
Note: Data were not available for 62 patient/doctor pairs. McNemar’s paired test P-
value¼0.001.
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Figure 3 Estimates of likelihood of cure of their disease by patients in
the four language groups in comparison to physician estimates.
Table 3 Influence of type of interpretation, if any, on understanding of disease status and expectation of cure
N
% accuracy in understanding
disease status
a N
Mean difference in
% expectation of cure
compared with doctors
b
Own language 20 60 25 26.2
Family interpreter 33 67 40 41.5
Other interpreter 5 60 7 28.6
Consultation in English without interpretation 32 44 39 41.0
aP¼0.30.
bP¼0.26 for overall comparisons across groups.
Table 4 (A) Influence of various factors on overall QoL (rated by the
patient). (B) Influence of the same factors on Performance status (rated by
the physician or research assistant)
P-value
a
Factor Univariate analysis Multivariate analysis
(A) Status of disease 0.017 0.0023
Ethnic group
Chinese vs English 0.058 0.10
Italian vs English 0.0001 0.006
Spanish vs English 0.10 0.19
University education 0.0014 0.05
Age 0.067 0.66
Gender 0.32 0.17
Marital status 0.71 0.57
(B) Status of disease 0.008 0.002
Ethnic group
Chinese vs English 0.048 0.04
Italian vs English 0.024 0.21
Spanish vs English 0.01 0.07
University education 0.069 0.14
Age 0.33 0.78
Gender 0.069 0.18
Marital status 0.13 0.46
aSince P-values are not corrected for multiplicity, the level of significance is set at
Po0.01.
Cancer and ethnic origin
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functional and physical domains (P¼0.002 and 0.0007, respec-
tively), but not with emotional or social/family domains.
DISCUSSION
This study provides support for the hypothesis that patients whose
first language is English have better knowledge and understanding
of their disease than those in the other language groups who were
of Southern European, South American or Chinese origin. There is
also some support for our second hypothesis, since although
accurate knowledge of disease stage had no detectable effect on
QoL, patients whose expectation of cure were closer to that of their
physicians had better QoL.
Our study has several limitations. Our sample size of 202
patients was chosen for reasons of feasibility and while it was
adequate to detect several important differences between the
language groups, the study lacked power to evaluate other aspects
such as language of consultation. All of the results will require
confirmation in an independent study. The Italian-speaking group
appeared to have particularly poor knowledge of disease and poor
QoL. However, many more Italian-speaking patients declined to
participate (for unknown reasons), and they also tended to be
older and less educated (Table 1). Although being Italian-speaking
predicted for poorer QoL in the multivariate analysis that included
other possible confounding variables, these socioeconomic differ-
ences may have introduced bias that might explain, in part, our
findings. Almost all of the LEP patients were first-generation
immigrants to Canada and it is not possible to separate the effects
of LEP and ethnic community within Canada from the influence of
immigration. Most patients received consultation in English with
either no translation, or translation provided by a family member,
and we are unable to assess the benefits of consultation in the
native language or of objective professional translators.
All groups had an inappropriately optimistic view of their
chance of cure, in agreement with other studies (Daugherty et al,
1995; Cheng et al, 2000), and patients with LEP had poorer
understanding of the status of their disease and their expectation
of cure. This may be due to poor communication with the doctor,
although cultural issues leading to denial or suppression of
unwelcome information may play a role, as well as the desire to
retain hope for cure (Mitchell, 1998). There are systematic
variations across ethnic groups in experience with illness,
expectations from treatment and acceptability of treatment (Juarez
et al, 1999). Ethnic origin and social position are known to
influence health-related behaviour, perceptions and meaning of
life; they may also influence explanations about sickness by health
professionals (Kleinman and Mendelsohn, 1978). There have been
few studies of knowledge of disease status in cancer patients of
different ethnic origins, but in general Latino and Black patients
appear to have less accurate knowledge than Whites and Asians
(Michielutte and Diseker, 1982; Stone and Siegel, 1986; Perez-
Stable et al, 1992; Meyerowitz et al, 1998). We found that patients
with LEP are less satisfied with information received and would
like more information about their disease. This indicates a need for
patient education and information to be provided in the patient’s
own language, or with professional interpreters who are less likely
to modify information given by the physician than family
members.
Our study suggests that Italian-speaking patients had poorest
and English-speaking patients best QoL, although only differences
between these two groups were statistically significant (Figure 4).
Differences in the Physical, Emotional, Functional and Social/
Family Well-being domains of QoL were of similar direction
among the ethnic groups. It is unknown whether this represents
true differences in QoL or a different frame of reference for
interpreting QoL between cultures. Although not definitive, our
findings are consistent with a greater effect of ethnic back-
ground on patient-evaluated QoL than on Performance status
evaluated by an objective observer. A relationship between QoL
and accuracy of knowledge about prognosis is also supported by
our study.
Although QoL instruments are now being applied widely in
international clinical trials that involve patients from diverse
cultural backgrounds, only a few published studies have assessed
the influence of ethnic origin on patient-rated QoL (Bernhard et al,
1998; de Haes and Olschewski, 1998). Equivalence has been
achieved in the evaluation of QoL among different populations
participating in some clinical trials but not in others (Hurny,
2000). In a study using the Rotterdam Symptom Checklist to assess
aspects of QoL in a crosscultural trial of adjuvant chemotherapy
and hormonal therapy for early breast cancer, there were
significant differences in both baseline QoL, and changes in QoL
across cultures (de Haes and Olschewski M). Significant differ-
ences in QoL between cultures before the initiation of adjuvant
chemotherapy were also observed in studies by the International
Breast Cancer Study Group (Hurny et al, 1992; Bernhard et al,
1998). A smaller study of the psychological adjustment of cancer
patients with high performance status undergoing radiotherapy in
Belgium and Turkey showed that Belgian patients experienced less
psychological distress than Turkish patients before starting
radiotherapy (Erbil et al, 1996). These findings are unlikely to be
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methods have been used to develop QoL instruments in different
languages (Aaronson et al, 1992; Ware et al, 1995, 1998; Bonomi
et al, 1996). The differences may be related to socioeconomic
status, education, access to health care, language, knowledge,
attitude toward doctors, treatment, patient behaviour and other
confounding factors (Adler et al, 1994; National Coalition of
Hispanic Health and Human Services Organizations, 1995). There
is a limited understanding of how patients from different cultural
backgrounds assess their QoL and what implications these cultural
differences might have on measurement of QoL in the context of
international clinical trials in cancer research. The differences
among language groups disclosed by the present study and others
suggest caution in generalising the effects of interventions on QoL
from a study of one homogenous population to patients of
different ethnic and cultural origins.
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